摘要
目的:研究在长效β_2激动剂/吸入糖皮质激素(ICS/LABA)基础上加用噻托溴铵Respimat~(LAMA)治疗高龄慢性阻塞性肺疾病(COPD)患者的疗效和安全性。方法:54例肺功能GOLD 3级或4级、并使用ICS/LABA的高龄COPD患者随机分为2组,1组加用噻托溴铵Respimat~,另1组继续原治疗方案,比较用药12个月时2组的肺功能变化、COPD评估测试评分变化、年急性加重人数和次数、药物相关不良事件。结果:用药12个月时LAMA+ICS/LABA组的第1秒用力呼气容积(FEV_1)、用力肺活量(FVC)年下降值低于ICS/LABA组,COPD评估测试评分改善值高于ICS/LABA组(均P<0.05);LAMA+ICS/LABA组急性加重的入院总次数低于ICS/LABA组(P<0.05);2组均未发生严重心血管事件,药物相关不良事件无统计学差异。结论:在ICS/LABA基础上加用噻托溴铵Respimat~可改善老年COPD患者的肺功能和临床症状,安全性和依从性好。
Objective: To investigate the efficacy and safety of Tiotropium Respimat combined with inhaled corticosteroid( ICS)/long-acting β2-agonist( LABA) in elderly patients with chronic obstructive pulmonary disease( COPD). Methods:Fifty-four elderly COPD patients,who were classified as GOLD 3 or 4 and received ICS/LABA treatment,were randomized into LAMA + ICS/LABA group and ICS/LABA group. Patients in LAMA + ICS/LABA group were treated with Tiotropium Respimat plus ICS/LABA,and those in ICS/LABA group were given ICS/LABA. The annual declines of FEV1 and FVC,the improvements in COPD Assessment Test( CAT) score,the number of COPD exacerbations leading to hospitalization,and the incidence of major adverse cardiovascular events and drug-related adverse reactions were compared between the two groups after 12 months. Results: After 12 months,LAMA + ICS/LABA significantly reduced the declines of FEV1 and FVC versus ICS/LABA. There were significant improvements in CAT score in LAMA + ICS/LABA group versus ICS/LABA group. Fewer COPD exacerbations leading to hospitalization were observed in the LAMA + ICS/LABA group than in ICS/LABA group. There was no significant difference in the incidence of drug-related adverse reactions between the two groups and no major adverse cardiovascular events were observed. Conclusion: In elderly COPD patients,addition of Tiotropium Respimat to ICS/LABA demonstrated significant improvements in lung function and health status compared to ICS/LABA.
作者
肖幸
余维巍
杨艳
张存泰
刘建
XIAO Xing;YU Wei-wei;YANG Yan;ZHANG Cun-tai;LIU Jian(Department of Geriatrics, Tongfi Hospital, Tongii Medical College, Huazhong University of Science and Technology, Wuhan 430030, Chin)
出处
《内科急危重症杂志》
2018年第1期16-18,共3页
Journal of Critical Care In Internal Medicine
关键词
慢性阻塞性肺疾病
噻托溴铵
老年
肺功能
Chronic obstructive pulmonary disease
Tiotropium
Elderly
Respiratory function